MAX Chat
Calendrier des promotions BrainsWay Ltd.
Calendrier avancé
Graphique simple
À propos de l'entreprise BrainsWay Ltd.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Paramètres de base
IPO date
1999-10-06
ISIN
US10501L1061
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 4 | 4 |
| P/BV | 2.62 | 6 |
| P/E | 56.12 | 2 |
Efficacité
| Nom | Signification | Grade |
| ROA | 3.71 | 1 |
| ROE | 5.62 | 2 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 1.03 | 8 |
| Debt/Ratio | 0.0596 | 10 |
| Debt/Equity | 0.5056 | 9 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 85.59 | 9 |
| Rentabilité Ebitda, % | -213.9 | 0 |
| Rentabilité EPS, % | -135 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 10.9 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 11.73 $ | 0 $ | 0 $ | -7.08 % | 0 % | 0 % |
| common.calendar.number_days.30d | 10.73 $ | 0 $ | 0 $ | +1.58 % | 0 % | 0 % |
| common.calendar.number_days.90d | 8.46 $ | 8.34 $ | 11.73 $ | +28.84 % | 0 % | 0 % |
| common.calendar.number_days.180d | 10.26 $ | 7.86 $ | 11.73 $ | +6.24 % | 0 % | 0 % |
| common.calendar.number_days.1y | 7.9 $ | 6.39 $ | 11.73 $ | +37.97 % | 0 % | 0 % |
| common.calendar.number_days.3y | 4.65 $ | 1.46 $ | 11.73 $ | +134.41 % | 0 % | 0 % |
| common.calendar.number_days.5y | 6.09 $ | 1.46 $ | 11.73 $ | +78.98 % | 0 % | 0 % |
| common.calendar.number_days.10y | 1.46 $ | 1.46 $ | 12.31 $ | +746.58 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 10.69 $ | 7.86 $ | 11.73 $ | +1.96 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Hadar Levy | Chief Executive Officer | 434k | 1974 (51 année) |
| Mr. Avner Hagai | Founder & Director | 43.65k | 1956 (69 années) |
| Prof. Abraham Zangen | Co-Founder, Member of Scientific Advisory Board & Director | 72.17k | 1970 (55 années) |
| Dr. Yiftach Roth Ph.D. | Founder & Chief Scientific Officer | 108k | 1971 (54 année) |
| Mr. Ido Marom | Chief Financial Officer | N/A | 1976 (49 années) |
| Mr. Menachem C. Klein Esq. | VP, General Counsel & Corporate Secretary | N/A | |
| Mr. Gilead Moiseyev | Chief Technology Officer | ||
| Mr. Ross Mitchell | Vice President of Global Marketing | ||
| Ms. Hillegonda Groen | Vice President of International Sales | 1969 (56 années) | |
| Dr. Richard A. Bermudes M.D. | Chief Medical Officer |
Informations sur l'entreprise
Adresse: Israel, Jerusalem, Bynet Building - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.brainsway.com
Site web: https://www.brainsway.com
